A Nationwide Cohort Study of Mortality Risk and Long-Term Prognosis in Infective Endocarditis in Sweden

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Ternhag, Anders ^a   Cederström, Agneta ^a   Törner, Anna ^a   Westling, Katarina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEART VALVE SURGERY; HUMAN; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STANDARDIZED MORTALITY RATIO; SWEDEN;

AGED; COHORT STUDIES; DEMOGRAPHY; ENDOCARDITIS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SWEDEN; TIME FACTORS;

EID: 84879928608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067519     Document Type: Article

References (25)

1. Mylonakis E, Calderwood SB, (2001) Infective endocarditis in adults. N Engl J Med 345: 1318-1330.
2. Tleyjeh IM, Steckelberg JM, (2006) Changing epidemiology of infective endocarditis. Curr Infect Dis Rep 8: 265-270.
3. Yiu KH, Siu CW, Lee KL, Fong YT, Chan HW, et al. (2007) Emerging trends of community acquired infective endocarditis. Int J Cardiol 121: 119-122.
4. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K, (1995) Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 74: 324-339.
5. Durack DT, Lukes AS, Bright DK, (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96: 200-209.
6. Que YA, Moreillon P, (2011) Infective endocarditis. Nat Rev Cardiol 8: 322-336.
7. Martinez-Selles M, Munoz P, Estevez A, del Castillo R, Garcia-Fernandez MA, et al. (2008) Long-term outcome of infective endocarditis in non-intravenous drug users. Mayo Clin Proc 83: 1213-1217.
8. Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr, (2012) Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med 172: 363-365.
9. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, et al. (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11: 450.
10. Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, et al. (2012) Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 59: 1968-1976.
11. Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, et al. (2012) Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54: 1230-1239.
12. Delahaye F, Ecochard R, de Gevigney G, Barjhoux C, Malquarti V, et al. (1995) The long term prognosis of infective endocarditis. Eur Heart J 16 Suppl B: 48-53.
13. Mokhles MM, Ciampichetti I, Head SJ, Takkenberg JJ, Bogers AJ, (2011) Survival of surgically treated infective endocarditis: a comparison with the general Dutch population. Ann Thorac Surg 91: 1407-1412.
14. Thuny F, Giorgi R, Habachi R, Ansaldi S, Le Dolley Y, et al. (2012) Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J 164: 94-101.
15. Murdoch D, Corey G, Hoen B, Miró J, Fowler V, et al. (2009) Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169: 463-473.
16. Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, et al. (1995) Clinical-features, site of involvement, bacteriological findings, and outcome of infective endocarditis in intravenous-drug-users. Archives of Internal Medicine 155: 1641-1648.
17. Tleyjeh I, Ghomrawi H, Steckelberg J, Montori V, Hoskin T, et al. (2010) Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias. J Clin Epidemiol 63: 130-135.
18. Hill E, Herregods M, Vanderschueren S, Claus P, Peetermans W, et al. (2008) Management of prosthetic valve infective endocarditis. Am J Cardiol 101: 1174-1178.
19. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, et al. (2002) Changing profile of infective endocarditis- Results of a 1-year survey in France. Jama-Journal of the American Medical Association 288: 75-81.
20. Lalani T, Cabell C, Benjamin D, Lasca O, Naber C, et al. (2010) Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 121: 1005-1013.
21. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ, (2003) Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis-A propensity analysis. Jama-Journal of the American Medical Association 290: 3207-3214.
22. Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P, (2011) Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis 11: 48.
23. Fernandez-Hidalgo N, Almirante B, Tornos P, Gonzalez-Alujas MT, Planes AM, et al. (2012) Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital. Clin Microbiol Infect 18: E522-530.
24. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, et al. (2002) Changing patient characteristics and the effect on mortality in endocarditis. Archives of Internal Medicine 162: 90-94.
25. Chu VH, Cabell CH, Benjamin DK, Kuniholm EF, Fowler VG, et al. (2004) Early predictors of in-hospital death in infective endocarditis. Circulation 109: 1745-1749.